{"meshTagsMajor":["Drug Resistance, Neoplasm"],"meshTags":["Biomarkers, Tumor","Breast Neoplasms","Drug Resistance, Neoplasm","Estrogen Receptor beta","Female","Humans","Immunohistochemistry","Predictive Value of Tests","Protein Isoforms","ROC Curve","Reproducibility of Results","Selective Estrogen Receptor Modulators","Tamoxifen","Treatment Outcome"],"meshMinor":["Biomarkers, Tumor","Breast Neoplasms","Estrogen Receptor beta","Female","Humans","Immunohistochemistry","Predictive Value of Tests","Protein Isoforms","ROC Curve","Reproducibility of Results","Selective Estrogen Receptor Modulators","Tamoxifen","Treatment Outcome"],"publicationTypes":["Comment","Journal Article"],"title":"Does ER-betacx really have no clinical importance in tamoxifen-treated breast cancer patients?","pubmedId":"19001345"}